Next-generation of targeted AAVP vectors for systemic transgene delivery against cancer
Open Access
- 2 August 2019
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 116 (37) , 18571-18577
Abstract
Significance: Over the past decade, we have used adeno-associated virus phage (AAVP) vectors for discovery, preclinical imaging, and translation therapy. However, hurdles remained with AAVP-mediated transgene delivery: both preinternalization (nonspecific protein adsorption, resulting in antibody-based neutralization) and postinternalization (endolysosomal degradation). As a proof-of-concept, we designed, developed, and validated a next-generation of targeted AAVP vectors that mitigate these obstacles to efficient gene delivery through the cis -genetic incorporation of specific peptide motifs to the phage capsid. On direct testing, the next-generation of targeted AAVP vectors proved superior to the original prototype in vitro and in mouse models of solid tumors, by avoiding degradation in pre- and postinternalization settings: An important methodological advance. We propose this platform should be considered for clinical applications.Keywords
This publication has 51 references indexed in Scilit:
- Dual Systemic Tumor Targeting with Ligand-Directed Phage and Grp78 Promoter Induces Tumor RegressionMolecular Cancer Therapeutics, 2012
- Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activityCancer Gene Therapy, 2012
- Bioadhesive Control of Plasma Proteins and Blood Cells from Umbilical Cord Blood onto the Interface Grafted with Zwitterionic Polymer BrushesLangmuir, 2012
- Combinatorial targeting and discovery of ligand-receptors in organelles of mammalian cellsNature Communications, 2012
- Systemic combinatorial peptide selection yields a non-canonical iron-mimicry mechanism for targeting tumors in a mouse model of human glioblastomaJournal of Clinical Investigation, 2011
- Bacteriophage applications: where are we now?Letters in Applied Microbiology, 2010
- Hemocompatible Mixed-Charge Copolymer Brushes of Pseudozwitterionic Surfaces Resistant to Nonspecific Plasma Protein FoulingLangmuir, 2009
- Launching a Novel Preclinical Infrastructure: Comparative Oncology Trials Consortium Directed Therapeutic Targeting of TNFα to Cancer VasculaturePLOS ONE, 2009
- A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imagingProceedings of the National Academy of Sciences, 2008
- pH-Dependent Lytic Peptides Discovered by Phage DisplayBiochemistry, 2006